echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > The Rockefeller Foundation and ACCESS Health publish authoritative reports, and Chinese experiences such as micro-medicine have been pushed globally.

    The Rockefeller Foundation and ACCESS Health publish authoritative reports, and Chinese experiences such as micro-medicine have been pushed globally.

    • Last Update: 2020-10-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The Rockefeller Foundation, an internationally renowned foundation, in partnership with ACCESS Heath International ("ACCESS Health"), has released a study entitled "Digital Technology and Public Health Together to Respond to the New Crown Pneumonia Outbreak: Bringing the Chinese Experience to the World", which provides a comprehensive picture of the impact of digital technology in six types of outbreak response.
    Twelve cases of digital war in China, including micro-medicine, Ali and JD.com, have been selected as important experiences in China's use of digital health technology to respond to the outbreak of neo-crown pneumonia, helping countries around the world to improve the effectiveness of their response strategies.
    the application of digital technology plays an important role in China's successful response to the new crown outbreak.
    It is understood that the report shows that in the early 2020 new crown pneumonia epidemic prevention and control process, digital health enterprises through their own advantages, in rapid response, epidemiological research, diagnosis and treatment, supportive activities, long-term management, integrated disease control system and other six aspects of the response, and analyzed its far-reaching impact.
    As one of the first enterprises to use digital technology to open up the "air battlefield" against the epidemic during the epidemic, micro-medicine was included as a representative case, the report details the micro-medical in all stages of anti-epidemic, different scenarios for the industry and the public professional information access, medical personnel coordination, online consultation, slow disease management, primary outbreak prevention and control and other medical health needs launched a variety of solutions.
    In the early stages of the outbreak, micro-doctors launched the "New Crown Pneumonia Real-Time Assistance Platform" to provide free consultation and advisory services to Wuhan and the people of the whole country, to sever patients, screening for minor illnesses, to reduce the risk of cross-infection in the process of patients going to the hospital, and has launched "psychological assistance zone", "Chinese medicine to fight the epidemic platform", "global anti-epidemic platform" and other services.
    As of the end of August, the micro-medical new crown pneumonia real-time relief platform has provided a total of 2.16 million free services, a total of more than 150 million visits, the highest number of daily visits more than 11 million;
    the demand for re-diagnosis and purchase of medicines for patients with chronic diseases, micro-medical Internet General Hospital provides online re-diagnosis and drug distribution services for some patients with common and chronic diseases.
    At the same time, in Tianjin, Tai'an, Wuhan, Jinan and other places have opened health insurance online payment, so that users can complete online follow-up and purchase drugs, enjoy one-stop medical and health services, for China's digital health industry has brought an important breakthrough.
    online, the "micro-medical mobile hospital", which includes 53 small inspection and inspection items in 7 categories and standardized diagnosis and treatment systems for 100 diseases, assists all regions to carry out efficient epidemic prevention and control work.
    , there are more than 80 micro-medical mobile hospitals in Gansu, Henan, Ningxia, Hubei and other places into service.
    report points out that micro-doctors' ability to respond quickly and mobilize coordinated resources efficiently in the prevention and control of the new coronary pneumonia epidemic highlights the unique value of platform-based Internet hospitals.
    Micro-medicine has polished a digital platform covering medicine, medicine, inspection, number and insurance, promoted the deep integration of medical and health service elements and the improvement of service closure, and built a new health care service system, so that in the face of sudden crisis, it can quickly and fully use the digital health platform and government, medical institutions and multi-partner effective collaboration, to achieve quality of service, efficiency and experience improvement.
    the release of the report, the Rockefeller Foundation, in cooperation with ACCESS Health, Yale University School of Public Health, organized an online round-table forum, Dr. Soumya Swaminathan, Chief Scientist of the World Health Organization, Dr. Naven Rao, Senior Vice President, Rockefeller Foundation, Yale University Public Health Dr. Sten Vermund, Dean of the Academy, President and President of ACCESS Health, and Dr. William A Haseltine, President of the China-U.S. Health Summit, are between key global opinion leaders, public health experts, researchers, and healthcare practitioners who discuss how to expand the impact of "digital epidemic resistance" and leverage digital health solutions to enhance their ability to respond to global crises. Deepali Khanna, managing director of
    Rockefeller Foundation Asia, said: "The large number of outbreak response strategies points to the critical task of integrating big data and digital health technologies into public health and emergency response systems.
    , digital health will strongly promote and promote the digital upgrading of the global health industry to better serve the health needs of people around the world.
    Name Source: Arterial Network Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mets Medical and may not be reproduced by any media, website or individual without authorization, and shall be reproduced with the words "Source: Mets Medicine".
    all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
    reproduce content at the same time does not represent the position of this site.
    leave a message here.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.